Search Results - "Zhangyuan, Guangyan"
-
1
VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway
Published in Oncogene (06-02-2020)“…Versican has been reported to participate in carcinogenesis in several malignant tumors. However, the accurate role of VersicanV1, a predominant isoform of…”
Get full text
Journal Article -
2
The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation
Published in Immunity (Cambridge, Mass.) (08-06-2021)“…Chronic inflammation plays a central role in hepatocellular carcinoma (HCC), but the contribution of hepatocytes to tumor-associated inflammation is not clear…”
Get full text
Journal Article -
3
Down-Regulation of LncRNA DGCR5 Correlates with Poor Prognosis in Hepatocellular Carcinoma
Published in Cellular physiology and biochemistry (01-01-2016)“…Background/Aims: Long non-coding RNAs (lncRNAs) have been reported to play pivotal roles in multiple tumors and can act as tumor biomarkers. In this study, we…”
Get full text
Journal Article -
4
Prognostic value of marital status on stage at diagnosis in hepatocellular carcinoma
Published in Scientific reports (31-01-2017)“…Marital status have been found as an independent prognostic factor for survival and spousal support could provide a survival advantage in various cancer types…”
Get full text
Journal Article -
5
Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway
Published in Oncogene (06-02-2020)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
6
Prognostic Value of Phosphotyrosine Phosphatases in Hepatocellular Carcinoma
Published in Cellular physiology and biochemistry (01-01-2018)“…Background/Aims: During the occurrence and progression of hepatocellular carcinoma (HCC), phosphotyrosine phosphatases (PTPs) are usually described as tumor…”
Get full text
Journal Article -
7
Is β-catenin mutation in murine hepatocytes sufficient to induce liver tumorigenesis?
Published in Journal of hepatology (01-08-2022)Get full text
Journal Article -
8
A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis
Published in Journal of hepatology (01-08-2023)“…Non-alcoholic steatohepatitis (NASH) is a chronic inflammatory disease that can further progress to cirrhosis and hepatocellular carcinoma. However, the key…”
Get full text
Journal Article -
9
14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes
Published in Cell death & disease (07-02-2018)“…Increasing evidence shows that the anti-tumor functions of tumor-infiltrating T lymphocytes (TILs) were inhibited significantly, but the underlying mechanisms…”
Get full text
Journal Article -
10
CD97 Promotes Tumor Aggressiveness Through the Traditional G Protein–Coupled Receptor–Mediated Signaling in Hepatocellular Carcinoma
Published in Hepatology (Baltimore, Md.) (01-11-2018)“…Cluster of differentiation 97 (CD97) is a member of the epidermal growth factor seven‐transmembrane family belonging to the class B G protein–coupled receptors…”
Get full text
Journal Article -
11
Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis
Published in Medicine (Baltimore) (01-05-2017)“…Cyclin B plays a crucial role in cancer cell cycle progression and is overexpressed in many human cancers, including breast cancer. However, the prognostic…”
Get full text
Journal Article -
12
PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis
Published in Theranostics (01-01-2020)“…: Inflammation plays a crucial role in the progression of nonalcoholic steatohepatitis (NASH). Protein tyrosine phosphatase receptor type O truncated isoform…”
Get full text
Journal Article -
13
PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis: Erratum
Published in Theranostics (01-01-2022)Get full text
Journal Article -
14
High preoperative serum globulin in hepatocellular carcinoma is a risk factor for poor survival
Published in Journal of Cancer (01-01-2019)“…: Serum globulin (GLB), albumin (ALB) and albumin/globulin ratio (AGR) have been reported as prognosis related factors for certain malignancies; however, the…”
Get full text
Journal Article -
15
lncRNA PCBP1-AS1 Aggravates the Progression of Hepatocellular Carcinoma via Regulating PCBP1/PRL-3/AKT Pathway
Published in Cancer management and research (01-01-2020)“…Hepatocellular carcinoma (HCC) is a very belligerent primary liver tumor with high metastatic potential. Aberrant expression of lncRNAs drives tumorous…”
Get full text
Journal Article -
16
Effect of lymph nodes count in node-positive gastric cancer
Published in Journal of Cancer (01-01-2019)“…Background: The retrieved lymph node (LN) count has been confirmed as a prognostic indicator in various cancers. However, the correlation between LN counts and…”
Get full text
Journal Article -
17
IncRNA PCBPI-ASI Aggravates the Progression of Hepatocellular Carcinoma via Regulating PCBP1/PRL-3/AKT Pathway
Published in Cancer management and research (31-07-2020)“…Background: Hepatocellular carcinoma (HCC) is a very belligerent primary liver tumor with high metastatic potential. Aberrant expression of lncRNAs drives…”
Get full text
Journal Article -
18
Differences in the prognostic value of tumor size on hepatocellular cancer-specific survival stratified by gender in a SEER population-based study
Published in United European gastroenterology journal (01-08-2019)“…Background and objective Tumor size is an important prognostic factor in cancers. This study aims at investigating the interaction between gender status and…”
Get full text
Journal Article -
19
Erratum: PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis: Erratum
Published in Theranostics (2022)“…[This corrects the article DOI: 10.7150/thno.42658.]…”
Get full text
Journal Article